PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 120 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2015. The put-call ratio across all filers is 3.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $18,000 | +38.5% | 29,000 | 0.0% | 0.00% | – |
| Q2 2016 | $13,000 | -97.6% | 29,000 | -94.4% | 0.00% | -100.0% |
| Q1 2016 | $543,000 | -22.5% | 517,456 | +117.9% | 0.01% | -30.8% |
| Q4 2015 | $701,000 | -5.1% | 237,456 | +1.5% | 0.01% | -13.3% |
| Q3 2015 | $739,000 | +332.2% | 233,856 | +710.4% | 0.02% | +400.0% |
| Q2 2015 | $171,000 | -44.5% | 28,856 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $308,000 | +12.0% | 28,856 | -1.4% | 0.01% | 0.0% |
| Q4 2014 | $275,000 | +37.5% | 29,256 | +12.3% | 0.01% | +20.0% |
| Q3 2014 | $200,000 | -35.9% | 26,056 | -77.3% | 0.01% | -54.5% |
| Q3 2013 | $312,000 | -6.9% | 114,800 | +23.6% | 0.01% | -15.4% |
| Q2 2013 | $335,000 | – | 92,849 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sageview Capital | 2,223,339 | $5,603,000 | 1.59% |
| Orbimed Advisors | 2,320,800 | $5,848,000 | 0.09% |
| F&C Asset Management plc | 1,854,808 | $4,665,000 | 0.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 56,500 | $142,000 | 0.04% |
| Yakira Capital Management, Inc. | 11,957 | $30,000 | 0.03% |
| Spectrum Management Group, LLC | 10,000 | $25,000 | 0.02% |
| Weiss Multi-Strategy Advisers LLC | 41,152 | $104,000 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 30,000 | $75,000 | 0.00% |
| PUTNAM INVESTMENTS LLC | 129,762 | $327,000 | 0.00% |
| Partnervest Advisory Services LLC | 220 | $1,000 | 0.00% |